Showing results (301-310 of 463) with videos related to

Sort By:
Pageof 47
Cancer|July 19, 2006
Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancerHoward S Hochster, Daniel G Haller, Aimery de Gramont, et al.
Cancer|June 28, 2007
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary siteBryan J Schneider, Basil El-Rayes, Jeffery H Muler, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Functional connectivity during drawing after upper extremity peripheral nerve surgery: enhanced connectivity between motor and visuomotor-parietal regionsS Gassass, M D Wheelock, N Kapil, et al.
Cancer|September 29, 2011
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancerPhilip A Philip, Michelle R Mahoney, Kyle D Holen, et al.
American Journal of Clinical Oncology|April 2, 2005
A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primaryBasil F El-Rayes, Anthony F Shields, Mark Zalupski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2014
Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single-arm phase II trialsPhilip A Philip, Kari Chansky, Michael LeBlanc, et al.
Nature Reviews. Clinical Oncology|March 18, 2023
Neoadjuvant therapy for pancreatic cancerChristoph Springfeld, Cristina R Ferrone, Matthew H G Katz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2013
First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinomaAndrew X Zhu, Philip J Gold, Anthony B El-Khoueiry, et al.
Pharmaceutical Research|April 28, 2010
Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancerSanjeev Banerjee, Asfar S Azmi, Subhash Padhye, et al.
Pancreas|April 21, 2004
Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell lineYiwei Li, Kerrie-Lynn Ellis, Shadan Ali, et al.
Pageof 47